(102 days)
Not Found
No
The description focuses on automated scanning and image display features, with no mention of AI/ML for image analysis or interpretation.
No.
The device is described as an "imaging tool" used to visualize tissue microstructure, not to provide therapy or treatment.
No
The device is described as an "imaging tool" for "evaluation of excised human tissue microstructure" and "providing two-dimensional, cross-section, real-time depth visualization." While it provides images that a clinician can use for evaluation, the text does not state that the device itself performs a diagnosis. It assists the clinician in viewing tissue.
No
The device description explicitly details hardware components like an interferometer, light sources, and mechanisms for automated scanning, indicating it is a hardware-based imaging system with accompanying software.
Based on the provided information, the OTIS 1.0 Optical Coherence Tomography System is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The intended use is "as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-section, real-time depth visualization." This describes a device that provides visual information about the tissue structure.
- Device Description: The description details an imaging system that uses optical coherence tomography to create images of tissue. It focuses on the imaging process and the features of the imaging system.
- Lack of Diagnostic Claims: There are no claims that the device performs a diagnostic test on the tissue sample, such as detecting specific biomarkers, analyzing chemical properties, or providing a diagnosis based on the imaging results. It provides images for the clinician to evaluate.
- Comparison to Predicate Devices: The predicate devices are also described as OCT imaging systems, further supporting the classification as an imaging tool rather than an IVD.
- Performance Studies: The performance study focuses on the image quality and the ability to identify tissue microstructure features compared to histopathology, which is consistent with validating an imaging system's ability to visualize structures.
IVD devices typically perform tests on biological samples (like tissue, blood, urine) to provide information for the diagnosis, monitoring, or treatment of a disease or condition. The OTIS 1.0 provides images of the tissue structure, which a clinician can then use in their evaluation, but it doesn't perform a diagnostic test itself.
N/A
Intended Use / Indications for Use
The OTIS 1.0 Optical Coherence Tomography System is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-section, real-time depth visualization.
Product codes
NOO, NQQ
Device Description
The Perimeter Optical Tissue Imaging System (OTIS) 1.0 is an imaging tool for use on excised human tissue. The Perimeter OTIS is based on optical coherence tomography (OCT) imaging which is similar to ultrasound, but uses non-ionizing, low-power optical radiation to produce high resolution, sub-surface images of a tissue sample. Due to the extremely high velocity of light, optical echoes (reflected and backscattered light from the sample) cannot be measured directly using a photodetector. Instead, OCT devices use an interferometer to compare a reference beam of light to the backscattered light returning from the tissue sample. The features in an OCT image are created by changes in the optical properties (namely scattering, absorption, and index of refraction) of the sample.
The Perimeter OTIS collects and displays OCT images of human tissue with comparable image quality to other previously 510(k)-cleared OCT imaging systems. However, rather than requiring the clinician to move his/her hand to collect "point-by-point" images, the Perimeter OTIS has automated the OCT scanning of the specimen surface, standardizing the image collection process.
The Perimeter OTIS also includes a white light image (e.g., photograph) of the specimen, to assist the clinician in viewing the OCT images with a reference to the white light image and the OCT image scan position. In addition, the Perimeter OTIS includes user interface options, such as the ability to "scroll" through the OCT images, across a specimen's surface, as well as to zoom and pan in more closely to examine areas of interest, as desired.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Optical Coherence Tomography (OCT)
Anatomical Site
excised human tissue
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Perimeter completed verification and validation activities under Perimeter Design Control procedures to ensure that verification studies demonstrated that outputs met input requirements, and that validation studies demonstrated that the Perimeter OTIS fulfilled the intended use and user needs.
Perimeter validated the usability of the OTIS per IEC 62366:2007 – Application of usability engineering to medical devices. Testing was performed with representative users in actual and simulated use environments.
Perimeter validated that the OTIS can obtain OCT images with sufficient image quality to identify tissue microstructure features as compared to histopathology, at a level comparable to other OCT imaging systems.
External laser, electrical, and EMC testing successfully demonstrated the safety of the Perimeter OTIS in its intended environment. Perimeter OTIS employs a near infrared super luminescent diode for optical image acquisition, as well as a surface sensing laser system. Both laser systems are classified as Class 1 laser, per IEC 60825-1.2014, requiring no special optical safety precautions. This laser classification of Class 1 is a lower (safer) laser classification level than the predicate devices (Class 3R).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles three human profiles facing to the right, stacked on top of each other, with flowing lines beneath them.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
May 13, 2016
Perimeter Medical Imaging, Inc. Elizabeth Munro Engineering Operations and Regulatory Lead 156 Front Street West, Suite 501 Toronto, M5J 2L6 CA
Re: K160240
Trade/Device Name: Perimeter OTIS™ 1.0 Optical Coherence Tomography System Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic Pulsed Echo Imaging System Regulatory Class: Class II Product Code: NOO Dated: April 8, 2016 Received: April 11, 2016
Dear Elizabeth Munro:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act and the limitations described below. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
The Office of Device Evaluation has determined that there is a reasonable likelihood that this device will be used for an intended use not identified in the proposed labeling and that such use could cause harm. Therefore, in accordance with Section 513(i)(1)(E) of the Act, the following limitation must appear in the warnings section of the device's labeling:
The safety and effectiveness of this device for diagnostic analysis (i.e. differentiating normal versus specific abnormalities) in any tissue microstructure or specified disease has not been evaluated."
1
Furthermore, the indication for use "the OTIS 1.0 Optical Coherence Tomography System is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-section, realtime depth visualization" must be prominently displayed in all labeling, including pouch box, and carton labels, instructions for use, and other promotional materials, in close proximity to the trade name, of a similar point size, and in bold print.
Please note that the above labeling limitations are required by Section 513(i)(1)(E) of the Act. Therefore, a new 510(k) is required before these limitations are modified in any way or removed from the device's labeling.
The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification if the limitation statement described above is added to your labeling.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
2
Sincerely yours,
William H. Maisel - S
William H. Maisel, MD, MPH Director (Acting) Office of Device Evaluation Deputy Center Director for Science Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K160240
Device Name
OTIS 1.0 Optical Coherence Tomography System
Indications for Use (Describe)
The OTIS 1.0 Optical Coherence Tomography System is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-section, real-time depth visualization.
Type of Use (Select one or both, as applicable)
|--|--|
X | Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
SECTION 6 510(K) SUMMARY
5
510(k) Summary
1. Basic Information - Submitter
| 510(k) Owner: | Perimeter Medical Imaging, Inc. |
|---|---|
| Address: | 156 Front Street West, Suite 501 |
| Toronto, Ontario, Canada, M5J 2L6 | |
| Official Contact: | Elizabeth Munro |
| Engineering Operations and Regulatory Lead | |
| (844) 492-9793 | |
| (416) 977-1955 (fax) | |
| emunro@perimetermed.com |
Date Summary Prepared: January 29, 2016
2. Device Name
Trade Name: Perimeter OTIS™ 1.0 Optical Coherence Tomography (OCT) System Common Name: Optical Coherence Tomography (OCT) System Classification Name: Ultrasonic pulsed echo imaging system Regulatory Classification: 21 CFR 892.1560 Product Code: NQQ Classification: Class II
3. Legally Marketed Predicate Devices
Imalux OCT Imaging Svstem. K033783 Imalux Niris™ Imaging System, K042894
4. Device Description
The Perimeter Optical Tissue Imaging System (OTIS) 1.0 is an imaging tool for use on excised human tissue. The Perimeter OTIS is based on optical coherence tomography (OCT) imaging which is similar to ultrasound, but uses non-ionizing, low-power optical radiation to produce high resolution, sub-surface images of a tissue sample. Due to the extremely high velocity of light, optical echoes (reflected and backscattered light from the sample) cannot be measured directly using a photodetector. Instead, OCT devices use an interferometer to compare a reference beam of light to the backscattered light returning from the tissue sample. The features in an OCT image are created by changes in the optical properties (namely scattering, absorption, and index of refraction) of the sample.
The Perimeter OTIS collects and displays OCT images of human tissue with comparable image quality to other previously 510(k)-cleared OCT imaging systems. However, rather than requiring the clinician to move his/her hand to collect "point-by-point" images, the
6
Perimeter OTIS has automated the OCT scanning of the specimen surface, standardizing the image collection process.
The Perimeter OTIS also includes a white light image (e.g., photograph) of the specimen, to assist the clinician in viewing the OCT images with a reference to the white light image and the OCT image scan position. In addition, the Perimeter OTIS includes user interface options, such as the ability to "scroll" through the OCT images, across a specimen's surface, as well as to zoom and pan in more closely to examine areas of interest, as desired.
5. Intended Use
The OTIS 1.0 Optical Coherence Tomography System is indicated for use as an imaging tool in the evaluation of excised human tissue microstructure by providing twodimensional, cross-sectional, real-time depth visualization.
| PRODUCT COMPARISON TABLE | |||
|---|---|---|---|
| Perimeter OTIS™ | |||
| [New Device] | Imalux Niris™ Imaging | ||
| System | |||
| [Predicate - K042894] | Imalux OCT Imaging | ||
| System | |||
| [Predicate - K033783] | |||
| Measurement Technique | Optical Coherence | ||
| Tomography | Optical Coherence | ||
| Tomography | Optical Coherence | ||
| Tomography | |||
| Center Wavelength | |||
| [NIR: 700 - 1400 nm] | 1325 ± 20 nm | 1310 ± 15 nm | 975 ± 15 nm |
| Optical Source | Super Luminescent Diode | Super Luminescent Diode | Super Luminescent Diode |
| Optical Radiation Safety | Safe for Indicated Use, | ||
| Class 1 Laser | Safe for Indicated Use, | ||
| Class 3R Laser | Safe for Indicated Use, | ||
| Class 3R Laser | |||
| Lateral Resolution | ≤ 50 μm | ≤ 50 μm | ≤ 50 μm |
| Lateral Range (x-axis): | |||
| Single B-scan | |||
| WF-OCT Scan | (1.7 mm) 2 mm | ||
| 500 mm [250 2 mm-strips] | 2 mm | ||
| [Point-by-point by clinician] | 2 mm | ||
| [Point-by-point by clinician] | |||
| Axial Resolution | |||
| [free space units] | ≤ 15 μm | ≤ 15um | ≤ 15 μm |
| In-depth tissue range | |||
| [free space units] | 1.5 mm in tissue | ||
| [minimum of 2.2 mm in free | |||
| space (7mm)] | 1.5 mm in tissue | ||
| [2.2 mm in free space] | 1.5 mm in tissue | ||
| [2.2 mm in free space] | |||
| Patient Applied Part | No Patient Applied Part | Handheld Fiber Optic | |
| Probe | Handheld Fiber Optic | ||
| Probe | |||
| Input Devices: | |||
| Keyboard | |||
| Pointing | |||
| Foot pedal (optional) | Yes | ||
| Yes | |||
| No | Yes | ||
| Yes | |||
| Yes - Optional | Yes | ||
| Yes | |||
| Yes - Optional | |||
| Electrical Voltage | |||
| Frequency | 108-132 V, | ||
| 60 Hz [North America Use] | 90-132 V, 198-264 V | ||
| 50/60 Hz | 90-132 V, 198-264 V | ||
| 50/60 Hz |
6. Substantial Equivalence Summary
7
Product and Quality Management Standards 7.
The Perimeter OTIS was designed and developed under design controls per 21 CFR 820.30, in addition to risk management, ISO 14971:2007 Application of Risk Management to Medical Devices.
In addition, testing was performed to ensure that the Perimeter OTIS complies with the following recognized standards:
- IEC 60825-1:2014, Safety of Laser Products Part 1: Equipment Classification . and Requirements
- AAMI ANSI IEC 62304 Medical Device Software Software Life Cycle . Management
- . AAMI ANSI ISO 15223-1:2012 Medical Devices – Symbols to be used with Medical Devices Labels, Labeling and Information to be Supplied - Part 1: General Requirements
- . AAMI ANSI ISO 10993-1:2014 Biological Evaluation of Medical Devices – Part 1: Evaluation and Testing within a Risk Management Process
- AAMI ANSI ES 60601-1: 2005/(R)2012, A1:2012, C1:2009/(R)2012 and . A2:2010/(R)2012 Medical Electrical Equipment - Part 1 - General Requirements for Basic Safety and Essential Performance
- IEC 60601-1-2:2007 Medical Electrical Equipment Part 1-2: General . Requirements for the Basic Safety and Essential Performance - Collateral Standard: Electromagnetic Compatibility - Requirements and Tests
8. Technological Characteristics
The Perimeter OTIS is substantially equivalent to the Imalux Niris™ Imaging System [K042894] and the Imalux OCT Imaging System [K033783] as all three devices use the same technology, Optical Coherence Tomography, and have the same intended use.
The Perimeter OTIS provides a standardized "stepping" of the OCT image acquisition probe across a pre-set scan area (e.g., 3 cm - 5 cm). This stepwise Perimeter OTIS surface scanning is analogous to a clinician manually moving the Imalux fiber optic probe step-by-step and acquiring an OCT image at each new position. However, unlike the manual probe image acquisition of the predicate devices, the Perimeter OTIS performs this surface image acquisition by using an automated mechanical stage and precise probe positioning, without probe-tissue direct contact,
The Perimeter OTIS and the predicate devices use near infrared (NIR) light to produce Optical Coherence Tomography images. The Perimeter OTIS center wavelength is 1325 ± 20 nm, while the Imalux Niris™ Imaging System [K042894] center wavelength is 1310
8
± 15 nm, and the Imalux OCT Imaging System [K033783] center wavelength is 975 ± 15 nm. Both predicate devices use a detachable, fiber optic probe which requires the operator to place and hold the probe on the correct location during image acquisition. The Perimeter OTIS positions the probe automatically during imaging the operator workload and ensuring consistent sample coverage. While the method of probe positioning is different, the intended use of the predicate devices and the Perimeter OTIS are the same and a comparison of their respective technologies and functional characteristics shows that the Perimeter OTIS is at least as safe and effective as the predicate devices for this intended use.
9. Performance and Safety Testing
Perimeter completed verification and validation activities under Perimeter Design Control procedures to ensure that verification studies demonstrated that outputs met input requirements, and that validation studies demonstrated that the Perimeter OTIS fulfilled the intended use and user needs.
Perimeter validated the usability of the OTIS per IEC 62366:2007 – Application of usability engineering to medical devices. Testing was performed with representative users in actual and simulated use environments.
Perimeter validated that the OTIS can obtain OCT images with sufficient image quality to identify tissue microstructure features as compared to histopathology, at a level comparable to other OCT imaging systems.
External laser, electrical, and EMC testing successfully demonstrated the safety of the Perimeter OTIS in its intended environment. Perimeter OTIS employs a near infrared super luminescent diode for optical image acquisition, as well as a surface sensing laser system. Both laser systems are classified as Class 1 laser, per IEC 60825-1.2014, requiring no special optical safety precautions. This laser classification of Class 1 is a lower (safer) laser classification level than the predicate devices (Class 3R).
10. Conclusions
Perimeter Medical Imaging, Inc. has demonstrated that the OTIS™ 1.0 Optical Coherence Tomography System has the same intended use and is substantially equivalent to its predicate devices, the Imalux Niris™ Imaging System and the Imalux OCT Imaging System. The Perimeter OTIS also complies with recognized standards and guidelines for electrical safety, laser safety, and biocompatibility. Testing has demonstrated that the device is as safe, as effective, and performs as well or better than the predicate devices.